Outset Medical, Inc. (OM) key performance indicators and operating metrics (9 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Gross Margin (GAAP) | 43.40 percent | FY2026-Q1 |
| Recurring Revenue from Tableau Consumables and Service | 22.5M | FY2026-Q1 |
| Gross Margin (Non-GAAP) | 43.80 percent | FY2026-Q1 |
| Product Revenue | 18.55M | FY2026-Q1 |
| Service and Other Revenue | 9.31M | FY2026-Q1 |
| Product Gross Margin | 52.40 percent | FY2026-Q1 |
| Operating Expenses (Non-GAAP, Excluding Stock-Based Compensation, Severance, and Litigation Charges) | 25.7M | FY2025-Q4 |
| Service and Other Gross Margin | 24.00 percent | FY2025-Q4 |
| Cumulative Treatments | 3M | FY2025-Q4 |
Back to OM overview · OM earnings · OM holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.